Business Context and Reporting Period
This Form 8-K was filed by NanoVibronix, Inc. on October 20, 2016. The report addresses corporate governance changes rather than financial performance. Note: The request metadata references "Envue Medical, Inc.," but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or operational metrics.
Material Changes
The primary material change reported is the expansion of the Company's senior management team and board of directors, as announced in a press release dated October 20, 2016.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, management commentary on operations, or specific risk factors. The document serves solely to disclose the personnel changes referenced in Item 8.01.
Investor Verification Checklist
- Verify the specific names and backgrounds of the new senior management and board members via the attached press release (Exhibit 99.1).
- Confirm the current corporate name and ticker status, as the metadata mentions "Envue Medical, Inc." while the filing is for "NanoVibronix, Inc."
- Review subsequent filings for financial data, as this 8-K contains no quantitative financial information.